Wumeiwan Jiawei Fang Use in Patients With Blepharospasm
Dry Eye Syndromes, Meige Syndrome, Blepharospasm
About this trial
This is an interventional treatment trial for Dry Eye Syndromes focused on measuring Wumeiwan Jiawei Fang, Blepharospasm, Meige syndrome
Eligibility Criteria
Inclusion Criteria: Idiopathic blepharospasm met the diagnostic criteria. The age ranges from 18 to 80 years. Liver Yang deficiency,mixed syndrome of cold and heat. Signed Informed consent Exclusion Criteria: Secondary blepharospasm due to keratoconjunctivitis, trichiasis, and blepharitis. Open eyelid disuse. hemifacial spasm. The patient had undergone eye surgery in the previous 6 months. Allergic to the ingredients in the medicine. Corneal lenses were worn during the study. A woman who is pregnant or breastfeeding. Combined with cardiovascular, cerebrovascular,Liver and kidney function, hematopoietic system serious primary disease, mental patients, combined with stroke patients. At the same time, use drugs that interfere with the evaluation of drug efficacy. Idiopathic blepharospasm is treated with other drugs.
Sites / Locations
- Eye Hospital, China Academy of Chinese Medical Sciences;GuangAnmen Hospital, China Academy of Chinese Medical Sciences;XiYuan Hospital, China Academy of Chinese Medical SciencesRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Wumeiwan Jiawei Fang
botulinum toxin A
This group will take Wumei pill granule orally.
In this group, Botulinum toxin type A (Lanzhou Biopharmaceutical Co. LTD.) was injected locally around the eye.